 |
|
Plants can be used to study how and why people respond differently to drugs
September 27, 2007RIVERSIDE, Calif. - While prescription medications work successfully to cure an ailment in some people, in others the same dose of the same drug can cause an adverse reaction or no response at all.
According to a research team led by Sean Cutler, an assistant professor of plant cell biology at UC Riverside, such variation in drug responses can be analyzed by studying much simpler organisms - like plants.
"The genetics behind variable drug responses is not peculiar to humans but exists also in other branches on the tree of life," Cutler said. "We can harness simple organisms to understand more about the genetics and biochemistry of variable drug responses, which could help uncover new factors that contribute to variable drug responses in humans."
Study results appear in the Sept. 23 online publication of Nature Chemical Biology.
Focusing on Arabidopsis thaliana, a weedy plant in the mustard family, Cutler's lab discovered a key protein in the plant that creates drug resistance. Called UGT (UDP-glycosyltransferase), the protein is a member of a family of proteins that also affect drug sensitivity in humans.
"Similar biochemical processes are affecting drug sensitivity in both plants and animals," said Cutler, who joined UCR's Department of Botany and Plant Sciences and the Center for Plant Cell Biology in January 2007. "These similarities suggest that plants can be useful for studying problems of human interest like drug responses."
In their research, Cutler and his research team first screened and tested thousands of drug-like compounds in the lab as they searched for new inhibitors of plant growth. In the process, they discovered a new molecule, called hypostatin, which acts like a drug in inhibiting plant growth in some Arabidopsis plants.
At the same time, the researchers grew Arabidopsis plants in a solution containing hypostatin, which allowed the plant cells to take up hypostatin.
Cutler and his team found that the plants' UGT activates hypostatin by adding a sugar molecule to it. They also found that in plants that had a genetically defective UGT, hypostatin did not work properly because no sugar molecules - necessary for activating hypostatin - were added to it; in such plants, therefore, growth was not affected.
"This mechanism is very similar to that seen in humans, where altered drug sensitivity can occur because of defective or atypical sugar-tagging proteins," Cutler said.
His lab made the discovery as part of its ongoing research aimed at identifying and characterizing new bioactive compounds in plants. Next in their research, Cutler and his colleagues plan to expand their search for other sugar-activated molecules, like hypostatin.
University of California - Riverside
Study results appear in the Sept. 23 online publication of Nature Chemical Biology.
Focusing on Arabidopsis thaliana, a weedy plant in the mustard family, Cutler's lab discovered a key protein in the plant that creates drug resistance. Called UGT (UDP-glycosyltransferase), the protein is a member of a family of proteins that also affect drug sensitivity in humans.
"Similar biochemical processes are affecting drug sensitivity in both plants and animals," said Cutler, who joined UCR's Department of Botany and Plant Sciences and the Center for Plant Cell Biology in January 2007. "These similarities suggest that plants can be useful for studying problems of human interest like drug responses."
In their research, Cutler and his research team first screened and tested thousands of drug-like compounds in the lab as they searched for new inhibitors of plant growth. In the process, they discovered a new molecule, called hypostatin, which acts like a drug in inhibiting plant growth in some Arabidopsis plants.
At the same time, the researchers grew Arabidopsis plants in a solution containing hypostatin, which allowed the plant cells to take up hypostatin.
Cutler and his team found that the plants' UGT activates hypostatin by adding a sugar molecule to it. They also found that in plants that had a genetically defective UGT, hypostatin did not work properly because no sugar molecules - necessary for activating hypostatin - were added to it; in such plants, therefore, growth was not affected.
"This mechanism is very similar to that seen in humans, where altered drug sensitivity can occur because of defective or atypical sugar-tagging proteins," Cutler said.
His lab made the discovery as part of its ongoing research aimed at identifying and characterizing new bioactive compounds in plants. Next in their research, Cutler and his colleagues plan to expand their search for other sugar-activated molecules, like hypostatin.
University of California - Riverside
Drug Response News and Current Drug Response Events RSSAntidepressants in suicide prevention
Antidepressants are the cornerstone of treatment of depressive disorders in health care. Their efficacy in treating depression is undisputable, although it leaves room for improvement.
Environmental enrichment can reduce cocaine use, researchers find
Simple environmental enrichment and increased social stress can both affect the level of individual drug use, according to new monkey research at Wake Forest University School of Medicine.
Johns Hopkins to participate in 1000 Genomes Project
Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.
Mental illness and drug addiction may co-occur due to disturbance in part of the brain
Why do mental illness and drug addiction so often go together" New research reveals that this type of dual diagnosis may stem from a common cause: developmental changes in the amygdala, a walnut-shaped part of the brain linked to fear, anxiety and other emotions.
Relapse from antidepressant medication may be lack of response to medication in the first place
A new study by Rhode Island Hospital researchers indicates that a relapse during antidepressant continuation treatment may be due to a relapse in patients who were not true drug responders.
Breakthrough developments in rheumatoid arthritis reported
Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis.
Mouse tests predict drug response in relapsing pancreatic cancer patients
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Novel mechanism of taxane resistance
Research Associate Chih-Jian Lih and others working in the laboratory of Dr. Stanley N. Cohen at Stanford University have pinpointed a gene that affects human cancer cells' sensitivity to chemotherapy-an important finding in the effort to increase the effectiveness of chemotherapy.
UCLA study finds same genes act differently in males and females
UCLA researchers report that thousands of genes behave differently in the same organs of males and females — something never detected to this degree.
Scientists develop new concept with potential to help predict how individuals may respond to drugs
Scientists from Imperial College London and Pfizer have developed a new method that could predict individual patient responses to drug treatments.
More Drug Response News Articles
 | Pdr Guide to Terrorism Response: A Resource for Physicians, Nurses, Emergency Medical Services, Law Enforcement, Firefighters (Pdr Guide to Terrorism Response) Authoritatively covers all forms of terrorist attack for all types of personnel. In addition to in-depth information on biological and chemical agents, it also provides basic response data on incendiary, explosive and nuclear attacks. Produced with leading terrorism experts. Three levels of information lets user choose the amount of detail needed. General preparedness - for hazard... |
 | Milady's Aesthetician Series: Common Drugs and Side Effects: A Handbook for the Aesthetician (Milady's Aesthetician Series) by Pamela Hill This guide is designed to act as a quick drug reference for the aesthetician who requires information on drugs, their purpose, drug interactions, and potential effects and side effects, especially as they pertain to skin conditions. This unique resource highlights drugs that will impact the skin, and as such, the ability to treat the skin with traditional topical or clinical treatments familiar... |
 | High Dilution Effects: Physical and Biochemical Basis (Handbooks of Behavioral Neurobiology) by Nirmal C. Sukul, Anirban Sukul Since the subject of high dilution effects is still a subject for debate, this volume provides evidence in support of effects from control clinical studies, clinical records from veteran physicians, controlled experiments on animals and plants, and in vitro tests without any organisms (Chapter II). An overview of the methods for preparing drugs at ultra high dilution is also provided as well as... |
 | Get the Dope on Dope: First Response Guide to Street Drugs, Volume 1 by S. C. Walton Award-winning street drug reference guide for parents, education professionals, emergency medical and hospital personnel, and law... |
 | Signals and Images: Contributions and Contradictions about High Dilution Research The GIRI – Groupe International de Recherche sur l´Infinitésimal – was created in 1986 with the aim to gather researchers toward the high dilution questions, such as hormesis, isopathy, homeopathy and the phenomenological and conceptual differences among them. This is the only international scientific society organised exclusively to promote multidisciplinary forums about these... |
 | Pharmacogenomics in Drug Discovery and Development (Methods in Molecular Biology) Since each human is genetically distinctive, responding differently to disease-causing factors as well as drugs, the field pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In Pharmacogenomics in Drug Discovery and Development, leading experts present methodical, state-of-the-art contributions covering topics from individual... |
 | Cancer Chemotherapy and Biotherapy: Principles and Practice ...easy to read, highly useable 3rd Edition of a classic provides the latest information on all aspects of anti-cancer... |
| When Drug Addicts Have Children: Reorienting Society's Response | |
 | Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) (Cancer Drug Discovery and Development) Extensive research has uncovered a set of molecular surveillance mechanisms commonly called checkpoints which tightly monitor cell-cycle processes. Today s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to... |
 | Statistical Methods for Dose-Finding Experiments (Statistics in Practice) Dose-finding experiments define the safe dosage of a drug in development, in terms of the quantity given to a patient. Statistical methods play a crucial role in identifying optimal dosage. Used appropriately, these methods provide reliable results and reduce trial duration and costs. In practice, however, dose-finding is often done poorly, with widely used conventional methods frequently being... |
| © 2008 BrightSurf.com |